Atlas Trials

A Decentralized Study to Evaluate Physical Activity and Cough Frequency Using Wearable Technology in Cystic Fibrosis

Clinical trial NCT04923464 · COMPLETED

Trial details

NCT number
NCT04923464
Sponsor
Vertex Pharmaceuticals Incorporated
Status
COMPLETED
Study type
OBSERVATIONAL
Cystic Fibrosis
Start date
2021-06-30
Primary completion
2021-12-20
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.